TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues.

AIDS-related non-Hodgkin's lymphoma (AIDS NHL) comprises a diverse and heterogeneous group of high-grade B cell tumors. Certain classes of AIDS NHL are associated with alterations in oncogenes or tumor-suppressor genes or infections by oncogenic herpesviruses. However, the clinically significant class of AIDS NHL designated immunoblastic lymphoma plasmacytoid (AIDS IBLP) lacks any consistent genetic alterations. We identified the TCL1 oncogene from a set of AIDS IBLP-associated cDNA fragments generated by subtractive hybridization with non-AIDS IBLP. Aberrant TCL1 expression has been implicated in T cell leukemia/lymphoma development, and its expression also has been seen in many established B cell tumor lines. However, TCL1 expression has not been reported in AIDS NHL. We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined. TCL1 protein expression is restricted to tumor cells in AIDS IBLP tissue samples analyzed with immunohistochemical staining. Hyperplastic lymph node and tonsil also exhibit strong TCL1 protein expression in mantle zone B cells and in rare interfollicular zone cells, whereas follicle-center B cells (centroblasts and centrocytes) show weaker expression. These results establish TCL1 as the most prevalent of all of the surveyed oncogenes associated with AIDS IBLP. They also indicate that abundant TCL1 expression in quiescent mantle zone B cells is down-regulated in activated germinal center follicular B cells in parallel to the known expression pattern of BCL-2. High-level expression in nonproliferating B cells suggests that TCL1 may function in protecting naïve preactivated B cells from apoptosis.

[1]  G. Pinkus,et al.  Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. , 1997, Blood.

[2]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. , 1997, Seminars in diagnostic pathology.

[3]  K. Rajewsky,et al.  Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. , 1993, The EMBO journal.

[4]  G. Gaidano,et al.  In vitro establishment of AIDS-related lymphoma cell lines: phenotypic characterization, oncogene and tumor suppressor gene lesions, and heterogeneity in Epstein-Barr virus infection. , 1993, Leukemia.

[5]  L. Larocca,et al.  Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. , 1998, Blood.

[6]  K. Lennert,et al.  Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Correlation with histologic features in 36 cases. French Study Group of Pathology for HIV-Associated Tumors. , 1994, American journal of clinical pathology.

[7]  F. Sigaux,et al.  MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations. , 1993, Oncogene.

[8]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[9]  D. Shibata,et al.  Rearrangements of the BCL-6 Gene in Acquired Immunodeficiency Syndrome-Associated Non-Hodgkin's Lymphoma: Association With Diffuse Large-Cell Subtype , 1994 .

[10]  D. Mason,et al.  Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. , 1990, The American journal of pathology.

[11]  G. Pinkus,et al.  The role of follicular and interdigitating dendritic cells in HIV-related lymphoid hyperplasia: localization of fascin. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[12]  Atypical lymphoid leukemia in ataxia telangiectasia. , 1978 .

[13]  F. Sigaux,et al.  Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia. , 1998, Blood.

[14]  P. Nowell,et al.  Molecular analysis of a t(7;14)(g35;g32) chromosome translocation in a T cell leukemia of a patient with ataxia telangiectasia , 1988, Cell.

[15]  G. Russo,et al.  Deregulated expression of TCL1 causes T cell leukemia in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Inghirami,et al.  Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. , 1988, Blood.

[17]  Masao Seto,et al.  Expression of the TCL1 Gene at 14q32 in B‐Cell Malignancies but Not in Adult T‐Cell Leukemia , 1998, Japanese journal of cancer research : Gann.

[18]  S. Alkan,et al.  Molecular and pathologic characterization of an AIDS-related body cavity-based lymphoma, including ultrastructural demonstration of human herpesvirus-8: a case report. , 1998, The American journal of surgical pathology.

[19]  Y. Pekarsky,et al.  Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Baggiolini,et al.  B Cell–attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1/CXCR5 , 1998, The Journal of experimental medicine.

[21]  G. Gaidano,et al.  Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. , 1997, Blood.

[22]  G. Gaidano,et al.  Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia , 1996, AIDS.

[23]  J. Diebold,et al.  Lymphomas associated with HIV infection. , 1997, Cancer surveys.

[24]  C. Arpin,et al.  Germinal center development , 1997, Immunological reviews.

[25]  S. Hamilton-Dutoit,et al.  AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. , 1991, The American journal of pathology.

[26]  G. Lenoir,et al.  Variable morphology of human immunodeficiency virus-associated lymphomas with c-myc rearrangements. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors, I , 1993 .

[27]  Aaron P. Campbell,et al.  Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Stein,et al.  Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. , 1994, Blood.

[29]  G. Gaidano,et al.  Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity. , 1998, The American journal of pathology.

[30]  G. Gaidano,et al.  Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. , 1993, Blood.

[31]  C. Boshoff,et al.  HIV infection and neoplasia , 1996, The Lancet.

[32]  G. Gaidano,et al.  Kaposi's sarcoma‐associated herpesvirus DNA sequences in AIDS‐related and AIDS‐unrelated lymphomatous effusions , 1996, British journal of haematology.

[33]  A. Ganser,et al.  Establishment of two Epstein-Barr virus negative Burkitt cell lines from a patient with AIDS and B-cell lymphoma. , 1988, Blood.

[34]  F. Sigaux,et al.  Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations. , 1996, Blood.

[35]  V. Beral,et al.  AIDS-associated non-Hodgkin lymphoma , 1991, The Lancet.

[36]  D. Vaux,et al.  Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation. , 1999, Cancer research.

[37]  Jason G. Cyster,et al.  A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 , 1998, Nature.

[38]  H. Koeffler,et al.  Mutation and protein expression of p53 in acquired immunodeficiency syndrome-related lymphomas. , 1993, Blood.

[39]  D. Knowles.  Molecular pathology of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. , 1997, Seminars in diagnostic pathology.

[40]  D. Albertson,et al.  Analysis of a T-cell tumor-specific breakpoint cluster at human chromosome 14q32. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[41]  E. Kohn,et al.  An improved method for construction of directionally cloned cDNA libraries from microdissected cells. , 1998, Cancer research.

[42]  A. Carbone,et al.  Annotation AIDS‐RELATED LYMPHOMAS: FROM PATHOGENESIS TO PATHOLOGY , 1995 .

[43]  Lyons Sf,et al.  The roles of human viruses in the pathogenesis of lymphoma. , 1998 .

[44]  M. McGrath,et al.  Pathogenesis of AIDS lymphomas. , 1994, AIDS.

[45]  Specific translocations characterize Burkitt's-like lymphoma of homosexual men with the acquired immunodeficiency syndrome. , 1983 .

[46]  G. Lenoir,et al.  Variable morphology of human immunodeficiency virus-associated lymphomas with c-myc rearrangements. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors, I. , 1993, Blood.

[47]  S. Orkin,et al.  Pathogenesis of B cell lymphoma in a patient with AIDS. , 1986, Blood.

[48]  G. Pinkus,et al.  Alterations in fascin-expressing germinal center dendritic cells in neoplastic follicles of B-cell lymphomas. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[49]  G. Gaidano,et al.  HHV‐8‐POSITIVE BODY‐CAVITY‐BASED LYMPHOMA: A NOVEL LYMPHOMA ENTITY , 1997, British journal of haematology.

[50]  G. Russo,et al.  Characterization and localization of the TCL-1 oncogene product. , 1994, Cancer research.

[51]  I. Maclennan,et al.  Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosis , 1991, European journal of immunology.

[52]  E. Jaffe.  Primary body cavity-based AIDS-related lymphomas. Evolution of a new disease entity. , 1996, American journal of clinical pathology.

[53]  M. McGrath,et al.  Molecular and immunophenotypic characterization of AIDS-associated, Epstein-Barr virus-negative, polyclonal lymphoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  M. Isobe,et al.  TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. , 1995, Blood.

[55]  T. Waldmann,et al.  Juxtaposition of the T-cell receptor alpha-chain locus (14q11) and a region (14q32) of potential importance in leukemogenesis by a 14;14 translocation in a patient with T-cell chronic lymphocytic leukemia and ataxia-telangiectasia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Diebold,et al.  Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors. , 1991, Archives of pathology & laboratory medicine.

[57]  E. Cesarman,et al.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. , 1996, Blood.

[58]  P. Pelicci,et al.  Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis , 1986, The Journal of experimental medicine.

[59]  J. Said,et al.  Polymerase chain reaction for bcl-2 in diagnostic lymph node biopsies. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[60]  P. Pelicci,et al.  Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986). , 1988, Annals of internal medicine.

[61]  R. Warnke,et al.  Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues. , 1993, Blood.

[62]  J. Said,et al.  Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring. , 1995, Human pathology.

[63]  M. Isobe,et al.  Chromosome walking on the TCL1 locus involved in T-cell neoplasia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[64]  M. Isobe,et al.  Identification of the TCL1 gene involved in T-cell malignancies. , 1994, Proceedings of the National Academy of Sciences of the United States of America.